Table 1.
Demographic and clinical patient characteristics.
Table 2.
Characteristics of bone marrow involvement.
Fig 1.
The PFS curves are provided according to the result of bone marrow involvement (a) BMB results (HR: 0.61 [0.13–2.78]; p = 0.517) (b) PET results (HR: 3.81 [1.23–11.87]; p = 0.013).
Fig 2.
OS curves are provided according to the result of bone marrow involvement. (a) BMB results (HR: 0.83 [0.10–6.77]; p = 0.864) (b) PET results (HR: 4.12 [1.03–16.5]; p = 0.03).
Fig 3.
Proposed algorithm for the evaluation of Bone Marrow Involvement (BMI) in DLBCL patients.